SecBot SecBot

AVDL

AVADEL PHARMACEUTICALS PLC
Nasdaq· Pharmaceutical Preparations· CIK 0001012477 Biotech & Drug Discovery
No price
Insider net
$0
no open-market trades · since Feb 12
New fund stakes
0
Q1 2026 13F · 1 exit

Price

Daily candles with volume.

Signal stack

Where each data set points today.

  • InsidersNO TRADES

    No open-market buys or sells since Feb 12. Recent filings are awards, exercises and tax withholding.

  • InstitutionsMIXED

    Q1 2026: 0 added (0 new), 1 trimmed or exited.

Who's buying

13F· Q1 2026
0
new positions
1
exit
FundMoveSharesValue
Neuberger Berman Group LLCEXIT0$0.00
Neuberger Berman Group LLCADD676,632$5.3M
FMR LLCADD221,348$1.7M
FMR LLCDOUBLED140,763$1.5M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

Last action Nov 2025
Recent actions
DateFirmActionRating
Nov 20, 2025Wells Fargo
MAINTAIN
MAINTAINEqual-Weight
Nov 7, 2025Wells Fargo
MAINTAIN
MAINTAINEqual-Weight
Oct 28, 2025UBS
DOWNGRADE
DOWNGRADENeutral
Oct 23, 2025Leerink Partners
DOWNGRADE
DOWNGRADEMarket Perform
Oct 23, 2025HC Wainwright & Co.
DOWNGRADE
DOWNGRADENeutral
Oct 22, 2025Jefferies
DOWNGRADE
DOWNGRADEHold

Insider ledger

Form 4
$0
open-market buys or sells · since Feb 12
DateInsiderTypeValue
Feb 12, 2026
Ende Eric J
Director
Feb 12, 2026
TO ISSUER33,000 sh
Feb 12, 2026
Divis Gregory J
Chief Executive Officer
Feb 12, 2026
TO ISSUER150,000 sh
Feb 12, 2026
Divis Gregory J
Chief Executive Officer
Feb 12, 2026
TO ISSUER$4.4M
Feb 12, 2026
Ende Eric J
Director
Feb 12, 2026
TO ISSUER8,057 sh
Feb 12, 2026
Ende Eric J
Director
Feb 12, 2026
TO ISSUER$4.6M
Feb 12, 2026
McCamish Mark Anthony
Director
Feb 12, 2026
TO ISSUER60,000 sh
Feb 12, 2026
McCamish Mark Anthony
Director
Feb 12, 2026
TO ISSUER$462.0K
Feb 12, 2026
Amin Naseem
Director
Feb 12, 2026
TO ISSUER49,500 sh

Washington

Corporate Lobbying

8 lobbying filings and 2 bills this company lobbies on, with spend, stage and how each bill touches it, are for subscribers.

Subscribe for Full Access
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Aug 5, 2026 Earnings calendar
AVDL Q2 2026 Earnings Scheduled, 2026-08-05
Mar 31, 2026 Inst.
Neuberger Berman Group LLC · EXIT
0 shares ($0.00)
Feb 12, 2026 Insider
Ende Eric J disposed of 33,000 shares
Director
Feb 12, 2026 Insider
Divis Gregory J disposed of 150,000 shares
Chief Executive Officer
Feb 12, 2026 Insider
Divis Gregory J disposed of 211,105 shares
Chief Executive Officer @ $21.00 ($4.4M)
Mar 31, 2025 Inst.
Neuberger Berman Group LLC · ADD
676,632 shares ($5.3M)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent